Expert Recommendation for Novel Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in HIV-Infected Adults

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic. SARS-CoV-2 vaccination is currently being actively promoted worldwide as a promising measure to combat the pandemic. However, human immunodeficiency virus (HIV)-infected individuals who manifest varying degrees of immunodeficiency and chronic inflammation may require special consideration with regards to vaccine types and the timing of immunization depending on specific clinical situations. The present recommendation provides a reference for SARS-CoV-2 vaccination in HIV-infected patients. © American Society of Clinical Oncology.